Overexpression of recombinant HIV-1 Subtype C Tat and Nef in a Salmonella vaccine vector

Overexpression of recombinant HIV-1 Subtype C Tat and Nef in a Salmonella vaccine vector

 

Nyasha Chin’ombe^1,2,&, Maribanyana Lebeko¹, Mankgopo Kgatle¹

 

¹Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Observatory 7925, Cape Town, South Africa, ²Department of Medical Microbiology, College of Health Sciences, University of Zimbabwe, P O Box A178 Avondale, Harare, Zimbabwe

 

 

^&Corresponding author
Nyasha Chin’ombe, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Observatory 7925, Cape Town, South Africa and the Department of Medical Microbiology, College of Health Sciences, University of Zimbabwe, P O Box A178 Avondale, Harare, Zimbabwe

 

 

 

 

HIV-1 Tat (transactivator) and Nef (negative factor) are important regulatory viral proteins [1]. Tat enhances viral replication and Nef down-regulates major histocompatibility complex (MHC) Class I molecule expression during HIV-1 infection [2]. The two antigens are expressed early in infection and are therefore potential targets for HIV-1 vaccine development [3]. Although Tat and Nef have previously been expressed in E. coli, their expression in Salmonella vaccine vectors has not previously been investigated widely. Live Salmonella vaccines expressing such foreign antigens have a great potential to be used as mucosal vaccines for HIV-1. They are capable of eliciting mucosal and systemic immune responses after oral administration [4]. They are also relatively easy and cheap to produce for mass vaccinations. Our research group previously developed a recombinant Salmonella expression plasmid in which green fluorescent protein (gfp) and HIV-1 Subtype C gag genes were cloned and expressed at very high levels [5,6]. We further demonstrated that oral vaccination of mice with the recombinant Salmonella expressing the two antigens could induce systemic antigen-specific immune responses [5,6]. In this study, we cloned HIV-1 Subtype C tat and nef genes into the backbone of the same expression plasmid and further investigated the expression of the antigens by the recombinant Salmonella vaccine.

 

 

The tat and nef genes (from primary HIV-1 Subtype C isolates, Du422 and Du151, respectively), codon-optimized for expression in Salmonella bacterium were cloned into the backbone of a prokaryotic expression plasmid previously reported by our group [5,6]. A his-tag DNA sequence was also cloned in-frame between each of the genes and the ?-galactosidase ?-gene (lacZ?). The generated plasmids, pGEM+hisTat and pGEM+hisNef were used to transform E. coli and Salmonella enterica serovar Typhimurium (aroC mutant) as previously described [5,6]. The IPTG-induced expression of the Tat and Nef antigens in E. coli was evaluated by SDS-PAGE as previously described [5,6]. The constitutive expression of the antigens by the recombinant Salmonella vaccine vector was also evaluated by SDS-PAGE as previously described [5,6]. Purification of Tat and Nef from the recombinant Salmonella was performed under both denaturing and native conditions using the QIA-Express Fast Start Ni+NTA kit (QIAGEN, Germany) according to manufacturer?s instructions. The bacterial protein from the different fractions (total bacterial cell lysate before purification, flow-through, first wash, second Wash and protein elutions fractions) was evaluated by SDS-PAGE. The SDS-PAGE was stained with Coomassie Blue dye.

 

 

HIV-1 tat and nef genes were successfully cloned into a prokaryotic expression plasmid previously developed by our research group. Two recombinant plasmids, pGEM+hisTat and pGEM+hisNef were successfully generated. Initial evaluation of Tat and Nef expression in E. coli showed very high expression of the antigens (Figure 1, A and B). The Tat and Nef protein bands were visible on Coomassie-stained SDS-PAGE gels (Figure 1 A, B). The specificity of the bands was confirmed by Western blotting (results not shown). The expression of the two foreign proteins was also very high in recombinant Salmonella (Figure 1). Both HIV-1 Tat and Nef were successfully purified in bulk from the recombinant Salmonella bacteria under denaturing conditions (Figure 2 A, B). The purified antigens were of high purity (Figure 2 A, B, Lanes 5-8). Under native conditions, only Nef, but not Tat could be purified (results not shown). The purified antigens were confirmed by Western blotting (results not shown).

 

 

One of the greatest challenges with the development of recombinant Salmonella vaccine vectors is to achieve high-level expression of the foreign antigens for successful delivery to the immune system. In our previous study, we successfully developed a Salmonellaexpression plasmid to use for the expression of foreign antigens (GFP and HIV-1 Gag) in Salmonella vaccine vectors [5,6]. Immunization of mice with the recombinant Salmonella expressing GFP or Gag induced specific immune responses [5,6]. In the current study, we used the same expression system to express HIV-1 Tat and Nef in Salmonella vaccine vector. The expression of the two foreign proteins was extremely high in both E. coli and Salmonella bacteria. To facilitate purification of Tat and Nef proteins from the bacteria, a his-Tag DNA sequence was cloned between the genes and the lacZ?. The his-tag did not affect the expression of the two foreign antigens. Although both Tat and Nef were purified in bulk under denaturing conditions, only only Nef could be purified under native conditions. This suggested that Tat was expressed mainly as inclusion bodies while Nef was expressed as both soluble and insoluble protein in Salmonella It is a common phenomenon that some antigens may form inclusion bodies when over expressed in E. coli or Salmonella. Using the Wilkinson-Harrison solubility model, the probabilities of insolubility for Tat and Nef was calculated and found to be 91% and 55% respectively.

Over expression of heterologous antigens in recombinant Salmonella vaccine vectors without causing metabolic burden to the bacteria is a key challenge [7,8]. In this study, we managed to express HIV-1 Tat and Nef at very high levels in a recombinant Salmonella vaccine vector due to a number of factors. The prokaryotic expression system which uses the transcription and translation domains in pGEM-Teasy plasmid (Promega, USA) have already previously been shown by our research group to be a good system for expression of other antigens such as GFP and HIV-1 Gag without much metabolic burden to the bacterial growth [5,6]. Fusing the genes to the lacZ?) peptide gene and use of the lac (bacterial) promoter enhanced the high expression of the antigens. The codon-optimization of the tat and nef genes also improved the high-level expression of the Tat and Nef proteins in both Salmonella and E. coli bacteria [11]. It is anticipated that the Salmonella expressing Tat and Nef may induce both B- and T- cell responses if used as oral vaccines in animal studies. We have already previously shown that recombinant Salmonella expressing GFP (mainly soluble) elicited humoral and CD8+ T cell responses while Gag which was expressed mainly as inclusion bodies elicited humoral and CD4+ T cell responses [5,6]. The purified HIV-1 antigens can potentially be used as reagents in immunoassays for the detection of HIV-1 antibodies in clinical human specimens or in animals vaccinated with HIV-1 Tat and Nef antigens. The antigens can also be used to develop protein-based subunit vaccines for induction of antibody responses against HIV-1 infection. The recombinant Salmonellaexpressing HIV-1 Tat and Nef developed during this study can potentially be used as candidate HIV vaccine.

 

 

The HIV-1 antigens, Tat and Nef were over-expressed in recombinant Salmonella vaccine. All the antigens were also purified in bulk. Therefore recombinant Salmonella is be good bacterial system for expressing foreign proteins at high levels. Such a system can also be used as a potential vaccine vector for HIV-1 antigens.

 

 

The authors declare no competing interests.

 

 

Nyasha Chin'ombe designed the whole study. All three authors performed the experiments and participated in the writing of the manuscript. All the authors have read and approved the final version of the manuscript.

 

 

We thank Microscience Pty Ltd (UK) for providing the AroC Salmonella strain used in this study. We also thank the staff in Medical Virology Division, University of Cape Town, for their support. This work was supported financially by a grant from the National Research Foundation of South Africa.

 

 

Figure 1: Expression of HIV-1 Subtype C Tat and Nef in recombinant E. coli and Salmonella bacteria. (A) Coomassie-stained SDS-PAGE showing Tat expression by recombinant E. coli. Lane M: Marker, Lane 1: E. coli expressing Tat, Lane 2: E. coli carrying an empty plasmid (negative control). The position of Tat protein band is indicated by an arrow. (B) Coomassie-stained SDS-PAGE showing Nef expression by recombinant E. coli. Lane M: Marker, Lane 1: E. coli expressing Nef, Lane 2: E. coli carrying an empty plasmid (negative control). The position of Nef protein band is indicated by an arrow. (C) Coomassie-stained SDS-PAGE showing Tat and Nef expression by recombinant Salmonella. Lane M: Marker, Lane 1: Salmonella expressing Tat, Lane 2: Salmonella expressing Nef, Lane 3: Salmonella carrying an empty plasmid (negative control). The positions of Tat and Nef protein bands are indicated by arrows.

Figure 2: Purification of HIV-1 Subtype C Tat and Nef from recombinant Salmonella under denaturing conditions (A) Coomassie-stained SDS-PAGE showing the purification of Tat from recombinant Salmonella. Lane M: Marker, Lane 1: Total bacterial cell lysate, Lane 2: Flow-through, Lane 3: First wash, Lane 4: Second wash, Lanes 5-8: Tat elution fractions. The position of Tat protein band is indicated by an arrow. (B) Coomassie-stained SDS-PAGE showing the purification of Nef from recombinant Salmonella. Lane M: Marker, Lane 1: Total bacterial cell lysate, Lane 2: Flow-through, Lane 3: First wash, Lane 4: Second wash, Lanes 5-8: Nef elution fractions. The position of Nef protein band is indicated by an arrow.

 

 

1. Emerman M, Malim MH. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science. 1998; 280(5371):1880-1884. PubMed | Google Scholar


2. Seelamgari A, Maddukuri A, Berro R, de la Fuente C, Kehn K, Deng L, Dadgar S, Bottazzi M E, Ghedin E, Pumfery A, Kashanchi F. Role of viral regulatory and accessory proteins in HIV-1 replication. Front Biosci. 2004; 9: 2388-2413. PubMed | Google Scholar


3. Titti F, Cafaro A, Ferrantelli F, Tripiciano A, Moretti S, Caputo A, Gavioli R, Ensoli F, Robert-Guroff M, Barnett S, Ensoli B. Problems and emerging approaches in HIV/AIDS vaccine development. Expert Opin Emerg Drugs. 2007; 12(1): 23-48. PubMed | Google Scholar


4. Kwon YM, Cox MM, Calhoun LN. Salmonella-based vaccines for infectious diseases. Expert Rev Vaccines. 2007; 6(2): 147-152. PubMed | Google Scholar


5. Chin?ombe N, Bourn WR, Williamson AL, Shephard EG. An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice. Gut Pathogens. 2009; 1(1): 9. PubMed | Google Scholar


6. Chin'ombe N, Bourn WR, Williamson AL, Shephard EG. Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice. Virology Journal. 2009; 6: 87. PubMed | Google Scholar


7. Galen JE, Levine MM. Can a 'flawless' live vector vaccine strain be engineered.Trends Microbiol. 2001; 9(8): 372-376. PubMed | Google Scholar


8. Kotton CN, Hohmann EL. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun. 2004; 72(10):5535-5547. PubMed | Google Scholar